Srikumar P. Chellappan PhD

Dr Chellappan obtained his PhD in Biochemistry from the Indian Institute of Science, Bangalore, India and did his post-doctoral training at Duke University Medical Center, Durham, NC. Subsequently, he went to become an Assistant Professor in the Department of Pathology at Columbia University in New York from 1992-2001. He joined Moffitt Cancer Center as an Associate Professor in 2001 and was promoted to Full Professor/Senior Member in 2006. He was recently named as the Chair of the new Department of Tumor Biology.

Dr Chellappan’s research interests include signal transduction and transcriptional regulation, especially in the context of tumour progression and metastasis. His laboratory has been focusing on the gene regulatory mechanisms in non-small cell lung cancer and how they can be targeted using novel drugs. His work has been published in journals like PNAS, Journal of Clinical Investigation, Molecular and Cellular Biology, Cancer Research etc. Dr Chellappan has served on various NIH Study sections as well as site visit teams and was a Charter member of the Tumor Progression and Metastasis Study Section. He has also served on the editorial board of multiple journals including Molecular Pharmacology and Molecular Cancer. His research has been continuously funded by the NIH since 1994.